COMP <GO>
CNC vs DGX // FREE CASH FLOW YIELD
Centene Corporation (NYSE) VS. Quest Diagnostics Incorporated (NYSE) • 15-METRIC TALLY: CNC 3
— DGX 10
▲ FREE CASH FLOW YIELD LEADER: CNC
LAST: $68.45 (-0.25%) • MKT CAP: $33.97B
fcf-yield
12.72%
LAST: $251.82 (-0.43%) • MKT CAP: $27.83B
fcf-yield
4.88%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNC VS. DGX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNC | DGX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 8.10% | 33.20% | -25.10 | DGX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.00% | 10.30% | -41.30 | DGX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 12.72% | 4.88% | +7.84 | CNC | /fcf-yield <GO> |
| Operating Margin | -4.40% | 14.10% | -18.50 | DGX | /operating-margins <GO> |
| Net Profit Margin | -3.80% | 9.00% | -12.80 | DGX | /net-margins <GO> |
| Revenue Growth (YoY) | 20.00% | 11.80% | +8.20 | CNC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.27% | -1.27 | DGX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.52 | 4.01 | -1.49 | DGX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | DGX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.9 | 69.4 | -15.50 | DGX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 1.01 | -0.07 | DGX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 26.1x | +9.90 | DGX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $33.97B | $27.83B | $6.15B | CNC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNC REV | DGX REV | CNC GROSS % | DGX GROSS % | CNC FCF | DGX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $174.58B | $11.04B | 8.1% | 33.2% | $4.32B | $1.36B |
| FY 2024 | $145.50B | $9.87B | 11.7% | 32.9% | -$490.0M | $909.0M |
| FY 2023 | $140.09B | $9.25B | — | — | $1.75B | $855.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNC // BETA 0.94
DGX // BETA 1.01